• Thumbnail for Metabolic dysfunction–associated steatotic liver disease
    Metabolic dysfunctionassociated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is a type of chronic...
    137 KB (15,203 words) - 03:09, 15 October 2024
  • Thumbnail for Fatty liver disease
    cirrhosis, liver cancer, and esophageal varices. The main subtypes of fatty liver disease are metabolic dysfunctionassociated steatotic liver disease (MASLD...
    38 KB (3,896 words) - 12:27, 19 October 2024
  • Thumbnail for Cirrhosis
    progressive form of metabolic dysfunctionassociated steatotic liver disease, previously called non-alcoholic fatty liver disease or NAFLD), heroin abuse...
    118 KB (12,408 words) - 06:11, 11 November 2024
  • Thumbnail for Hypertriglyceridemia
    cardiovascular disease. Chronically elevated serum triglyceride levels are a component of metabolic syndrome and metabolic dysfunction-associated steatotic liver disease...
    18 KB (1,673 words) - 19:37, 30 October 2024
  • Thumbnail for Portal vein
    visceral fat into the liver, leading to hepatic insulin resistance and metabolic dysfunctionassociated steatotic liver disease. Measuring approximately...
    14 KB (1,383 words) - 19:30, 22 September 2024
  • Thumbnail for Steatohepatitis
    Steatohepatitis (category Diseases of liver)
    constitute fatty liver changes. There are 2 main types of fatty liver disease (FLD): Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) (previously...
    8 KB (744 words) - 04:39, 14 October 2024
  • Thumbnail for Metabolic syndrome
    high-density lipoprotein (HDL). Metabolic syndrome is associated with the risk of developing cardiovascular disease and type 2 diabetes. In the U.S....
    58 KB (6,850 words) - 14:27, 11 November 2024
  • Thumbnail for Insulin-like growth factor 1
    predicting fibrosis, but not steatosis, in people with metabolic dysfunctionassociated steatotic liver disease. Medical conditions: acromegaly (especially when...
    35 KB (4,575 words) - 09:00, 2 November 2024
  • Thumbnail for Semaglutide
    Semaglutide (category Experimental drugs developed for non-alcoholic fatty liver disease)
    lowering liver enzymes (transaminitis) and improving certain radiologically observed features of metabolic dysfunctionassociated steatotic liver disease. French...
    73 KB (6,160 words) - 06:48, 21 November 2024
  • Thumbnail for SUCNR1
    Sanyal AJ (September 2023). "Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient...
    71 KB (8,861 words) - 07:35, 24 October 2024